Kinesiotape and Core Exercises in Federated Boxers
23. Januar 2020 aktualisiert von: Investigación en Hemofilia y Fisioterapia
Kinesiotape® and Core Exercises in the Improvement of Nonspecific Lumbar Pain, Trunk Flexion, Resistance of the Spinal Erector Musculature and Effort Perception in Federated Boxers
Introduction. Nonspecific lumbar pain is a very common cause of sports decline in boxers, possibly due to the repetitive movements of flexion and rotation in their sport, so the investigators believe it is interesting to seek an intervention that helps these athletes to reduce their incidence.
Aim. To improve non-specific low back pain, range of motion of trunk flexion; the muscular resistance of the spinal erectors and the subjective perception of the effort in federated boxers older than 18 years.
Study design. Randomized, multicentric and double-blind clinical trial with follow-up period.
Methods. 60 federated boxers of legal age will be recruited, who will be randomly assigned to the study groups: experimental (Core and Kinesiotape® exercises) and control (Core exercises and Kinesiotape® tubes without tension). The intervention will last 4 weeks, with 2 weekly sessions, lasting 35 minutes. Three evaluations will be carried out (pre-treatment, post-treatment and follow-up) for the dependent variables. The analysis of normality will be carried out with the Kolmogorov Smirnov test and in case of homogeneity of the sample, with the t-student test of related samples and the ANOVA of repeated means, the difference between the evaluations and the intra e effect will be calculated. intersubject, respectively.
Expected results. It is expected to observe the effectiveness of the Core and Kinesiotape® exercises in the perception of nonspecific lumbar pain, the range of movement of trunk flexion and lumbar resistance, and the perception of effort.
Studienübersicht
Status
Abgeschlossen
Bedingungen
Intervention / Behandlung
Studientyp
Interventionell
Einschreibung (Tatsächlich)
60
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienorte
-
-
Comunity Of Madrid
-
Madrid, Comunity Of Madrid, Spanien, 28670
- Universidad Europea de Madrid
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
18 Jahre bis 45 Jahre (Erwachsene)
Akzeptiert gesunde Freiwillige
Ja
Studienberechtigte Geschlechter
Männlich
Beschreibung
Inclusion Criteria:
- Federated boxers
- Over 18 years
- Male
- With non-specific back pain that does not incapacitate them for the realization of their sport or work activity.
Exclusion Criteria:
- Federated boxers with lumbar injury with medical diagnosis
- Who are or have been treated by pharmacological or physiotherapy in the last 6 months
- Presenting allergies or alterations of the skin
- Not sign the informed consent document.
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Experimental
Each session will be held in a group and will last 35 minutes, taking place 2 sessions a week, in a period of 4 weeks.
The intervention will be carried out at the end of the training session and after drying the sweat of the area to be treated.
After the training, the Core and Kinesiotape exercises with tension and stretching will be performed
|
The intervention through Core exercises will consist in the application of a protocol of four Core stabilization exercises.
This protocol will consist of the following exercises: abdominal plate, bilateral plate, hunting dog and gluteal bridge.
The intervention by Kinesiotape will be performed with the subject in a sitting position with both arms relaxed throughout the body, while the physiotherapist will place the bases of the strips without tension, on the sacroiliac joint.
Once this is done, proceed to ask the subject to lean forward applying the rest of the strip, except the distal edge, with a tension of between 15 and 25%, finally requesting the subject to rejoin straining the distal base without tension, on the twelfth dorsal spinous process.
|
|
Aktiver Komparator: Control
Each session will be held in a group and will last 35 minutes, taking place 2 sessions a week, in a period of 4 weeks.
The intervention will be carried out at the end of the training session and after drying the sweat of the area to be treated.
After the training, the Core and Kinesiotape exercises technique will be performed without tension or stretching
|
The intervention through Core exercises will consist in the application of a protocol of four Core stabilization exercises.
The objective of the application of the technique based on this type of exercise is to improve muscle strength, endurance and neuromuscular control.
This protocol will consist of the following exercises: abdominal plate, bilateral plate, hunting dog and gluteal bridge.
The intervention by Kinesiotape will be performed with the subject in a sitting position with both arms relaxed throughout the body, while the physiotherapist will place the bases of the strips without tension, on the sacroiliac joint.
Once this is done the tape will be placed without tension and sn movement of the subject.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change from baseline pain perception after treatment and at month: VAS
Zeitfenster: Screening visit, within the first seven days after treatment and after one month follow-up visit
|
Pain perception measurement will be measured with the visual analogue scale, which is represented by a line from 0 mm to 100 mm indicating at the ends the states of 'no pain '(0) and' as much pain as it can bear' (10) .
The EVA scale is measured as the distance between the line of 'no pain 'and that marked by the subject.
A change greater than 13 mm between the two would be considered clinically relevant
|
Screening visit, within the first seven days after treatment and after one month follow-up visit
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change from baseline pain perception at the pressure after treatment and at month: pressure algometer
Zeitfenster: Screening visit, within the first seven days after treatment and after one month follow-up visit
|
The perception of pain at the pressure will be calculated with a pressure algometer (model Baselin de Quirumed), whose assessment varies from 0 to 10 kg.
It consists of a rubber block of 1 cm2, performing the evaluation by applying pressure in the paravertebral area to the height of the 3rd and 4th lumbar spinous processes, with the subject in the prone position.
The unit of measure is kg. the subject indicating the perception of pain by means of an acoustic signal (for example: "stop").
The greater the units of measurement (kg), the better the perception of the subject's pain.
|
Screening visit, within the first seven days after treatment and after one month follow-up visit
|
|
Change from baseline perception of effort after treatment and at month
Zeitfenster: Screening visit, within the first seven days after treatment and after one month follow-up visit
|
To measure the perception of effort, the Borg scale will be used.
This measuring instrument is designed to linearly describe exercise intensity and heart rate.
In the simplest version of this scale, the numbers from 0 to 10 are used.
The number 0 indicates a non-existent perception of the effort, and the number 10 implies an extremely strong perception of the intensity of the effort.
|
Screening visit, within the first seven days after treatment and after one month follow-up visit
|
|
Change from baseline trunk flexion after treatment and at month
Zeitfenster: Screening visit, within the first seven days after treatment and after one month follow-up visit
|
The trunk flexion will be evaluated by applying the Schober test.
A mark will be made at the lumbosacral junction, and two other marks on the skin (one at 10 cm above the lumbosacral junction and another at 5 cm below).
The subjects should flex their trunk to the maximum without flexing the knees and at the same time measure the distance between the upper and lower marks.
The unit of measurement of this test is in centimeters, where a higher score indicates a greater range of trunk movement in flexion.
|
Screening visit, within the first seven days after treatment and after one month follow-up visit
|
|
Change from baseline trunk flexion after treatment and at month
Zeitfenster: Screening visit, within the first seven days after treatment and after one month follow-up visit
|
The trunk flexion will be evaluated the finger-ground test.
The subject will stand in an anthropometric box, and perform a trunk flexion with the extended legs stretching both arms towards the ground and facing the palms towards their legs.
The subjects must maintain that position for two seconds until the measurement is taken.
The unit of measurement of this test is in centimeters, where a higher score indicates a greater range of trunk movement in flexion.
|
Screening visit, within the first seven days after treatment and after one month follow-up visit
|
|
Change from baseline resistance of the lumbar extensor musculature after treatment and at month
Zeitfenster: Screening visit, within the first seven days after treatment and after one month follow-up visit
|
The resistance of the lumbar extensor musculature will be evaluated through the Biering Sorensen test.
This test consists of placing the subject in a prone position with the lower limbs fixed to the stretcher and the upper part of the body extended from the hip to the head, towards the outside of the stretcher.
You will be asked to hold the horizontal position with your arms crossed over your chest as long as possible.
This test has by unit of measurement the time (in seconds), where at higher valuation, greater resistance of the extensor musculature.
|
Screening visit, within the first seven days after treatment and after one month follow-up visit
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Tatsächlich)
12. März 2019
Primärer Abschluss (Tatsächlich)
20. April 2019
Studienabschluss (Tatsächlich)
20. Juni 2019
Studienanmeldedaten
Zuerst eingereicht
4. März 2019
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
6. März 2019
Zuerst gepostet (Tatsächlich)
7. März 2019
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
27. Januar 2020
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
23. Januar 2020
Zuletzt verifiziert
1. Januar 2020
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- COREKT
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Nein
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Nein
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .